Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Status:
Completed

Trial end date:
2007-01-01

Target enrollment:

Participant gender:

This trial will evaluate the efficacy and safety of ucb 44212 as add-on therapy in subjects with focal epilepsy.

Phase 2

UCB Pharma

Etiracetam